478 related articles for article (PubMed ID: 19395429)
1. Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption.
Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M
J Psychopharmacol; 2009 Jul; 23(5):475-86. PubMed ID: 19395429
[TBL] [Abstract][Full Text] [Related]
2. Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers.
Paterson LM; Nutt DJ; Ivarsson M; Hutson PH; Wilson SJ
J Psychopharmacol; 2009 Jul; 23(5):487-94. PubMed ID: 19351801
[TBL] [Abstract][Full Text] [Related]
3. A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers.
Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M
Psychopharmacology (Berl); 2007 May; 191(4):943-50. PubMed ID: 17225163
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical effects of the hypnotic Zolpidem in the neonatal ferret.
Hsu N; Jha SK; Coleman T; Frank MG
Behav Brain Res; 2009 Jul; 201(1):233-6. PubMed ID: 19428639
[TBL] [Abstract][Full Text] [Related]
5. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
Seidel WF; Maze M; Dement WC; Edgar DM
J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
[TBL] [Abstract][Full Text] [Related]
6. Armodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the rat.
Wisor JP; Dement WC; Aimone L; Williams M; Bozyczko-Coyne D
Pharmacol Biochem Behav; 2006 Nov; 85(3):492-9. PubMed ID: 17134745
[TBL] [Abstract][Full Text] [Related]
7. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat.
Edgar DM; Seidel WF
J Pharmacol Exp Ther; 1997 Nov; 283(2):757-69. PubMed ID: 9353396
[TBL] [Abstract][Full Text] [Related]
8. Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats.
Ivarsson M; Paterson LM; Hutson PH
Eur J Pharmacol; 2005 Oct; 522(1-3):63-71. PubMed ID: 16223479
[TBL] [Abstract][Full Text] [Related]
9. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.
Monti JM; Alvariño F; Monti D
Sleep; 2000 Dec; 23(8):1075-84. PubMed ID: 11145322
[TBL] [Abstract][Full Text] [Related]
10. Prior sleep with zolpidem enhances the effect of caffeine or modafinil during 18 hours continuous work.
Batéjat D; Coste O; Van Beers P; Lagarde D; Piérard C; Beaumont M
Aviat Space Environ Med; 2006 May; 77(5):515-25. PubMed ID: 16708532
[TBL] [Abstract][Full Text] [Related]
11. CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat.
Edgar DM; Seidel WF; Gee KW; Lan NC; Field G; Xia H; Hawkinson JE; Wieland S; Carter RB; Wood PL
J Pharmacol Exp Ther; 1997 Jul; 282(1):420-9. PubMed ID: 9223583
[TBL] [Abstract][Full Text] [Related]
12. Effects of amphetamine, diazepam and caffeine on polysomnography (EEG, EMG, EOG)-derived variables measured using telemetry in Cynomolgus monkeys.
Authier S; Bassett L; Pouliot M; Rachalski A; Troncy E; Paquette D; Mongrain V
J Pharmacol Toxicol Methods; 2014; 70(1):86-93. PubMed ID: 24878255
[TBL] [Abstract][Full Text] [Related]
13. Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep.
Dijk DJ; James LM; Peters S; Walsh JK; Deacon S
J Psychopharmacol; 2010 Nov; 24(11):1613-8. PubMed ID: 19487320
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide-Y Y2-receptor agonist, PYY3-36 promotes non-rapid eye movement sleep in rat.
Akanmu MA; Ukponmwan OE; Katayama Y; Honda K
Neurosci Res; 2006 Mar; 54(3):165-70. PubMed ID: 16378653
[TBL] [Abstract][Full Text] [Related]
15. A Standardized Phlorotannin Supplement Attenuates Caffeine-Induced Sleep Disruption in Mice.
Kwon S; Yoon M; Lee J; Moon KD; Kim D; Kim SB; Cho S
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30845636
[TBL] [Abstract][Full Text] [Related]
16. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
Fisher SP; Davidson K; Kulla A; Sugden D
J Pineal Res; 2008 Sep; 45(2):125-32. PubMed ID: 18298466
[TBL] [Abstract][Full Text] [Related]
17. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
Jhaveri M; Seal B; Pollack M; Wertz D
Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740
[TBL] [Abstract][Full Text] [Related]
18. Nelotanserin, a novel selective human 5-hydroxytryptamine2A inverse agonist for the treatment of insomnia.
Al-Shamma HA; Anderson C; Chuang E; Luthringer R; Grottick AJ; Hauser E; Morgan M; Shanahan W; Teegarden BR; Thomsen WJ; Behan D
J Pharmacol Exp Ther; 2010 Jan; 332(1):281-90. PubMed ID: 19841476
[TBL] [Abstract][Full Text] [Related]
19. D(1)/D(2) receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice.
Qiu MH; Qu WM; Xu XH; Yan MM; Urade Y; Huang ZL
Pharmacol Biochem Behav; 2009 Nov; 94(1):16-23. PubMed ID: 19604496
[TBL] [Abstract][Full Text] [Related]
20. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
